Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Olanzapine + Fluoxetine
- Therapeutic area
- CNS & mental health
- Drug class
- Antipsychotics
- ATC
- N06CA
- Strength
- 25 mg + 3 mg
- Dosage form
- Capsule
- Pack
- 30's
- Registration no.
- 113235
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-09-23 03:18
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
PKR 323.33 to 339.30 (+4.9%) between 5 Nov 2025 and 17 Aug 2026 · 2 official price records · pack 30's
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. Olanzar - F 3/25mg 25 mg + 3 mg, 30's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/olanzar-f-3-25mg-25-mg-3-mg-113235-30s-mega-pharmaceuticals-limited/ (accessed 23 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 339.30 | 2026-08-17 | 2026-09-22 | DRAP PharmaPrice Index (refreshed from snapshot #84) | Current |
| PKR 323.33 | 2025-11-05 | 2026-08-09 | DRAP PharmaPrice Index | Historical |
Other listed brands
Cite this record
Medicine record · DRAP registration 113235Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.
